Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Quantumscape Corp (QS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Quantumscape Corp — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.14 (market cap $4.02B), while Quantumscape Corp trades at $3.85 (market cap $2.43B). The key difference: Edgewise Therapeutics Inc. Common Stock is the larger of the two by market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Quantumscape Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Quantumscape Corp for 37 Days on average.
| EWTX | QS | |
|---|---|---|
Market Cap | $4.02B | $2.43B |
Volume | 1,446,128 | 14,407,354 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.35 | $18.44 |
52-Week Low | $14.89 | $3.93 |
Typical Hold Time | 0 Days | 37 Days |
Enterprise Value | $3.56B | $1.64B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
QuantumScape (QS) trades at $4.12, down 3.51% with a bearish technical outlook despite oversold RSI readings. The company remains pre-revenue with significant losses (-$435.05M net income in 2025) and negative ROE/ROA. Recent news highlights commercialization delays and insider selling, while analyst consensus shows 73% hold ratings with a $10.35 price target representing 151% upside potential.
QS presents high-risk speculation with substantial upside if solid-state battery technology succeeds, but faces execution risks and cash burn. The stock trades near 52-week lows with negative cash flow trends, requiring careful risk management given the 5+ year commercialization timeline and competitive threats in EV battery development.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Quantumscape Corp
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →
